Nektar Therapeutics NKTR Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$158.1M-12.7% | -$164.08M-30.0% | -$128M+23.9% | -$129.53M+26.9% | -$140.3M+20.2% | ||
| $751K-76.6% | $1.03M-76.6% | $1.17M-79.5% | $1.97M-69.4% | $3.21M-54.9% | ||
| $12.11M-37.9% | $12.65M-41.5% | $15.26M-36.6% | $17.58M-34.5% | $19.51M-33.6% | ||
| -$203.76M-15.2% | -$208.51M-18.7% | -$189.74M-7.5% | -$184.91M-5.8% | -$176.87M+6.2% | ||
| $187K-85.8% | $171K-88.4% | $612K-50.9% | $1.16M+89.9% | $1.31M+123% | ||
| —— | —— | $58.65M-41.2% | $199.63M+81.4% | $167M+41.3% | ||
| $710.11M+581,956% | $180.57M+329% | $141.98M+238% | $314K-99.3% | $122K-99.7% | ||
| —— | —— | —— | —— | -$9.75M— | ||
| -$203.94M-14.5% | -$208.68M-17.8% | -$190.35M-7.1% | -$186.07M-6.1% | -$178.19M+5.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Nektar Therapeutics's cash flow data come from?
- Every line is extracted from Nektar Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.